Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pasireotide for Digestive Leakage After CRS + HIPEC
NCT04826432Phase 2Terminated
- Sponsor
- Gustave Roussy
- Start
- Sep 2020
- Primary completion
- Feb 2024
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pasireotide LAR in Anastomotic Leak (AL), sponsored by Gustave Roussy. Started Sep 2020; status: terminated.
02
Drugs
pasireotide LAR
03
Conditions
Anastomotic Leak (AL)
Beyond the preview
Go deeper on NCT04826432.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04826432.